NCT03527199View on ClinicalTrials.gov

Prostate Cancer Patients With Biochemical Recurrence

CompletedOBSERVATIONAL

Enrollment

65

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

April 10, 2023

Study Completion Date

April 10, 2023

Conditions

Patients With Prostate Cancer

Interventions

DIAGNOSTIC_TEST

Pelvic CT or MRI + MDP bone scan + or - 18F-NaF PET/CT(SOC)

Standard of care-Pelvic CT or MRI and MDP bone scan + or - 18F-NaF PET/CT

Trial Locations (1)

63110

John Cochran VA Medical Center St. Louis, St Louis

Sponsors

Collaborators (1)

Blue Earth Diagnostics

All Listed Sponsors

collaborator

Blue Earth Diagnostics

INDUSTRY

lead

Medhat Osman

FED

NCT03527199 - Prostate Cancer Patients With Biochemical Recurrence | Biotech Hunter | Biotech Hunter